Cargando…

Analysis of the clinical characteristics and prognosis of adult de novo acute myeloid leukemia (none APL) with PTPN11 mutations

We discuss the clinical characteristics and prognostic significance of adult individuals with PTPN11 mutations who have developed acute myeloid leukemia (AML) (none acute promyelocytic leukemia). Next generation sequencing and Sanger sequencing were used to detect 51 gene mutations, and multiplex-PC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheng, Li, Liu, Yajiao, Zhu, Yingying, Zhou, Jingfen, Hua, Haiying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655689/ https://www.ncbi.nlm.nih.gov/pubmed/38025540 http://dx.doi.org/10.1515/med-2023-0830

Ejemplares similares

Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia
por: Fobare, Sydney, et al.
Publicado: (2022)

Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis
por: Guarnera, Luca, et al.
Publicado: (2022)

Influence on therapeutic outcome of platelet count at diagnosis in patients with de novo non-APL acute myeloid leukemia
por: Zhang, Yujiao, et al.
Publicado: (2023)

Comprehensive analysis of PTPN family expression and prognosis in acute myeloid leukemia
por: Liu, Yong, et al.
Publicado: (2023)

Clinical Challenges and Consequences of Measurable Residual Disease in Non-APL Acute Myeloid Leukemia
por: Jentzsch, Madlen, et al.
Publicado: (2019)

Differentiation Syndrome in Acute Leukemia: APL and Beyond
por: Woods, Ashley C., et al.
Publicado: (2023)

Mutated Ptpn11 alters leukemic stem cell frequency and reduces the sensitivity of acute myeloid leukemia cells to Mcl1 inhibition
por: Chen, Lili, et al.
Publicado: (2015)

Dasatinib response in acute myeloid leukemia is correlated with FLT3/ITD, PTPN11 mutations and a unique gene expression signature
por: Tavor, Sigal, et al.
Publicado: (2020)

Charting a course through the acute promyelocytic leukemia (APL)-like nebula: the enigmatic cousins of APL
por: Ghiaur, Alexandra, et al.
Publicado: (2023)

A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma
por: Liu, Yajiao, et al.
Publicado: (2023)

Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
por: Hou, Hsin-An, et al.
Publicado: (2016)

Acute promyelocytic leukemia (APL): a review of the literature
por: Jimenez, Joaquin J., et al.
Publicado: (2020)

APL Congress
por: Gjerløv, Per, et al.
Publicado: (1973)

An Externally Validated Nomogram for Predicting the Overall Survival of Patients With Diffuse Large B-Cell Lymphoma Based on Clinical Characteristics and Systemic Inflammatory Markers
por: Liu, Yajiao, et al.
Publicado: (2023)

APL : a short course
por: Pakin, Sandra
Publicado: (1973)

Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis
por: Gausdal, G, et al.
Publicado: (2013)

None
Publicado: (1999)

Activating Mutations in PTPN11 and KRAS in Canine Histiocytic Sarcomas
por: Takada, Marilia, et al.
Publicado: (2019)

Noonan syndrome: rhGH treatment and PTPN11 mutation
por: Wu, Xian, et al.
Publicado: (2023)

Acute Promyelocytic Leukemia (APL): Comparison Between Children and Adults
por: Testi, Anna Maria, et al.
Publicado: (2014)

PTPN11 Gene Mutations and Its Association with the Risk of Congenital Heart Disease
por: Xu, Zi-qing, et al.
Publicado: (2022)

APL2 in depth
por: Thomson, Norman D, et al.
Publicado: (1995)

APL 76 Conference
por: Hunter, G Truman
Publicado: (1976)

International Conference on APL
por: Van der Linden, Gijsbert
Publicado: (1980)

LEOPARD syndrome in an infant with severe hypertrophic cardiomyopathy and PTPN11 mutation
por: Ganigara, Madhusudan, et al.
Publicado: (2011)

Acute promyelocytic leukemia presenting as pulmonary thromboembolism: Not all APLs bleed
por: Vaid, Ashok K, et al.
Publicado: (2015)

Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with Protein Tyrosine Phosphatase Non-Receptor Type 11 Gene Mutation
por: Huang, Rui, et al.
Publicado: (2023)

And then there were none
por: Christie, Agatha, 1890-1976

And then there were none
por: Silva, Jose Tiago, et al.
Publicado: (2019)

Case Report: ANXA2 Associated Life-Threatening Coagulopathy With Hyperfibrinolysis in a Patient With Non-APL Acute Myeloid Leukemia
por: Ruhnke, Leo, et al.
Publicado: (2021)

Cytogenetic Characteristics of de novo Acute Myeloid Leukemia in Southern Vietnam
por: Thao, Lai Thi Thanh, et al.
Publicado: (2023)

Pan-cancer analysis revealing that PTPN2 is an indicator of risk stratification for acute myeloid leukemia
por: Wang, Xuanyu, et al.
Publicado: (2023)

Concomitant deletion of Ptpn6 and Ptpn11 in T cells fails to improve anticancer responses
por: Ventura, Pedro M O, et al.
Publicado: (2022)

Mutational spectrum and prognosis in NRAS-mutated acute myeloid leukemia
por: Wang, Shujuan, et al.
Publicado: (2020)

Myocardial Infarction as an Initial Presentation of Essential Thrombocythemia With Calreticulin (CALR) Mutation (None Type 1, None Type 2)
por: Afana, Mohammad, et al.
Publicado: (2023)

APL programs for the mathematics classroom
por: Thomson, Norman D
Publicado: (1989)

Editorial: Welcome to APL Bioengineering
por: Cooper-White, Justin
Publicado: (2017)

Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation
por: Jongmans, Marjolijn C J, et al.
Publicado: (2011)

KRAS Analysis in 34 Noonan Syndrome Patients without PTPN11 Mutation
por: Yamamoto, Kaoru, et al.
Publicado: (2007)

LEOPARD Syndrome with a Sporadic PTPN11 Mutation in a Saudi Patient
por: Alshamrani, Hussein M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7t9bctaaa55jh74or37oht7540